Loading...
We have set up our new Discord server! Share your feedback and find like-minded people! Join our Discord
- Ticker
- ETNB
- Price
- 5.92
- Stock movement up
- +0.39 (7.05%)
- Company name
- 89bio Inc
- Exchange
- (NASDAQ ,
- Currency
- USD )
- Sector
- Healthcare >Biotechnology
- Market cap
- 696.09M
- Ent value
- 684.87M
- Price/Sales
- 2974.72
- Price/Book
- 1.84
- Div yield
- -
- Div growth
- -
- Growth years
- -
- FCF payout
- -0.00%
- Trailing P/E
- -
- Forward P/E
- -
- PEG
- -
- EPS growth
- -
- 1 year return
- -41.62%
- 3 year return
- 19.84%
- 5 year return
- -22.14%
- 10 year return
- -
Last updated: 2025-04-14
iO Charts is a Seeking Alpha partner
iO Charts is a Seeking Alpha partner
DIVIDENDS
ETNB does not pay dividends or no data was received
iO Charts is a Seeking Alpha partner
iO Charts is a Seeking Alpha partner
VALUATION
Valuation Ratios
Loading...
Valuation Ratios data
| Trailing P/E | - |
| Price to OCF | - |
| Price to FCF | - |
| Price to EBITDA | - |
| EV to EBITDA | - |
Valuation (Sales/Book Value)
Loading...
Valuation (Sales/Book Value) data
| Price to Sales | 2974.72 |
| Price to Book | 1.84 |
| EV to Sales | 2926.79 |
iO Charts is a Seeking Alpha partner
iO Charts is a Seeking Alpha partner
FINANCIALS
Per share
Loading...
Per share data
| Current share count | 117.58M |
| EPS (TTM) | -2.70 |
| FCF per share (TTM) | -2.62 |
Income statement
Loading...
Income statement data
| Revenue (TTM) | 234.00K |
| Gross profit (TTM) | 197.00K |
| Operating income (TTM) | -303.86M |
| Net income (TTM) | -288.96M |
| EPS (TTM) | -2.70 |
| EPS (1y forward) | -2.91 |
Margins
Loading...
Margins data
| Gross margin (TTM) | 84.19% |
| Operating margin (TTM) | -129853.42% |
| Profit margin (TTM) | -123487.18% |
Balance Sheet
Loading...
Please create a free account or log in to access this chart
Balance Sheet data
| Cash | 91.41M |
| Net receivables | 0.00 |
| Total current assets | 456.21M |
| Goodwill | 0.00 |
| Intangible assets | 0.00 |
| Property, plant and equipment | 1.78M |
| Total assets | 458.30M |
| Accounts payable | 19.49M |
| Short/Current long term debt | 2.02M |
| Total current liabilities | 39.13M |
| Total liabilities | 80.19M |
| Shareholder's equity | 378.10M |
| Net tangible assets | 0.00 |
Cash flow
Loading...
Please create a free account or log in to access this chart
Cash flow data
| Operating cash flow (TTM) | -280.54M |
| Capital expenditures (TTM) | 4.00K |
| Free cash flow (TTM) | -280.54M |
| Dividends paid (TTM) | 693.00 |
Financial returns
Loading...
Please create a free account or log in to access this chart
Financial returns data
| Return on Equity | -76.42% |
| Return on Assets | -63.05% |
| Return on Invested Capital | -69.73% |
| Cash Return on Invested Capital | -67.70% |
iO Charts is a Seeking Alpha partner
iO Charts is a Seeking Alpha partner
STOCK INFORMATION
Stock chart
Loading...
Stock price data
| Open | 5.85 |
| Daily high | 6.00 |
| Daily low | 5.55 |
| Daily Volume | 1.61M |
| All-time high | 41.77 |
| 1y analyst estimate | 30.13 |
| Beta | 0.98 |
| EPS (TTM) | -2.70 |
| Dividend per share | - |
| Ex-div date | - |
| Next earnings date | 7 May 2025 |
Downside potential
Loading...
Downside potential data
| ETNB | S&P500 | |
| Current price drop from All-time high | -85.83% | -12.04% |
| Highest price drop | -95.00% | -56.47% |
| Date of highest drop | 9 May 2022 | 9 Mar 2009 |
| Avg drop from high | -62.42% | -11.07% |
| Avg time to new high | 105 days | 12 days |
| Max time to new high | 1288 days | 1805 days |
iO Charts is a Seeking Alpha partner
iO Charts is a Seeking Alpha partner
COMPANY DETAILS
Marketcap
696.09M
Marketcap category
Small-cap
Description
89bio, Inc., a clinical-stage biopharmaceutical company, focuses on the development and commercialization of therapies for the treatment of liver and cardio-metabolic diseases. Its lead product candidate is pegozafermin, a glycoPEGylated analog of fibroblast growth factor 21 for the treatment of nonalcoholic steatohepatitis; and for the treatment of severe hypertriglyceridemia. The company was incorporated in 2018 and is headquartered in San Francisco, California.
Employees
70
Website
Investor relations
-
SEC filings
CEO
Rohan Palekar
Country
USA
City
San Francisco
Stock type
Common stock
CCC status
-
Dividend Frequency
-
EVENTS AND PRESENTATIONS
EventsPresentations
Loading...
iO Charts is a Seeking Alpha partner
iO Charts is a Seeking Alpha partner
UNDERSTAND THE BUSINESS
Loading...
COMPANY NEWS
Seeking AlphaPress releases
iO Charts is a Seeking Alpha partnerNext page